Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MAP2K4 | P45985 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | ALPL | P05186 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | TTK | P33981 | 1/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.38 |
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27584640 | 0.83 | HPGDS (0.40) | ALDH1A1KDM4EHPGDNPC1RAB9A | |
| SCHEMBL27861076 | 0.79 | MEN1 (0.42) | ALDH1A1KDM4EHPGDALPLRAB9A | |
| SCHEMBL453506 | 0.76 | KDM4E (0.48) | ALOX15ALDH1A1KDM4EHPGDGAA | |
| SCHEMBL2048675 | 0.74 | ALOX15 (0.43) | ALOX15ALDH1A1KDM4EHPGDGAA | |
| SCHEMBL170101 | 0.74 | ALOX15 (0.43) | ALOX15ALDH1A1KDM4EHPGDGAA | |
| SCHEMBL8776626 | 0.74 | ALOX15 (0.43) | ALOX15ALDH1A1KDM4EHPGDGAA | |
| SCHEMBL15348468 | 0.74 | HPGD (0.43) | ALOX15ALDH1A1KDM4EHPGDGAA | |
| SCHEMBL2387037 | 0.74 | AKT2 (0.44) | ALOX15ALDH1A1KDM4EHPGDGAA | |
| SCHEMBL454022 | 0.74 | ALDH1A1 (0.47) | ALOX15ALDH1A1KDM4EHPGDGAA | |
| SCHEMBL7637229 | 0.74 | ALOX15 (0.43) | ALOX15ALDH1A1KDM4EHPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12291547-B2 | Synthesis of 3-azido-3-deoxy-D-galactopyranose | UNIVERSITé LAVAL (CA) | 2025-05-06 | — | — | US | claimed |
| US-20220251129-A1 | SYNTHESIS OF 3-AZIDO-3-DEOXY-D-GALACTOPYRANOSE | UNIVERSITé LAVAL (CA) | 2022-08-11 | — | — | US | claimed |
| EP-3983423-A1 | SYNTHESIS OF 3-AZIDO-3-DEOXY-D-GALACTOPYRANOSE | Université Laval (CA) | 2022-04-20 | — | — | EP | claimed |
| WO-2020248068-A1 | SYNTHESIS OF 3-AZIDO-3-DEOXY-D-GALACTOPYRANOSE | UNIVERSITé LAVAL (CA) | 2020-12-17 | — | — | WO | claimed |
| US-12291547-B2 | Synthesis of 3-azido-3-deoxy-D-galactopyranose | UNIVERSITé LAVAL (CA) | 2025-05-06 | — | — | US | disclosed |
| US-20230127345-A1 | SELENOGALACTOSIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH GALECTIN AND THE USE THEREOF | GALECTIN SCIENCES, LLC | 2023-04-27 | — | — | US | disclosed |
| CN-109071585-B | Seleno galactoside compound for preventing and treating galectin related diseases and application thereof | 卡莱克汀科学有限责任公司 | 2022-08-16 | — | — | CN | disclosed |
| US-20220251129-A1 | SYNTHESIS OF 3-AZIDO-3-DEOXY-D-GALACTOPYRANOSE | UNIVERSITé LAVAL (CA) | 2022-08-11 | — | — | US | disclosed |
| EP-3983423-A1 | SYNTHESIS OF 3-AZIDO-3-DEOXY-D-GALACTOPYRANOSE | Université Laval (CA) | 2022-04-20 | — | — | EP | disclosed |
| WO-2020248068-A1 | SYNTHESIS OF 3-AZIDO-3-DEOXY-D-GALACTOPYRANOSE | UNIVERSITé LAVAL (CA) | 2020-12-17 | — | — | WO | disclosed |
| EP-3707149-A1 | SELENOGALACTOSIDE COMPOUNDS FOR THE TREATMENT OF SYSTEMIC INSULIN RESISTANCE DISORDERS AND THE USE THEREOF | Galectin Sciences, LLC (US) | 2020-09-16 | — | — | EP | disclosed |
| CN-111527097-A | Seleno galactoside compounds for treating systemic insulin resistance disorder and uses thereof | 卡莱克汀科学有限责任公司 | 2020-08-11 | — | — | CN | disclosed |
| CN-102766102-A | Preparation method and application of fluorine-containing triazole compound | UNIV ZHEJIANG TECHNOLOGY | 2012-11-07 | — | — | CN | disclosed |
| CN-102603660-A | Preparation method of 1H-1,2,3-triazole compound | UNIV ZHEJIANG TECHNOLOGY | 2012-07-25 | — | — | CN | disclosed |
| CN-101792438-B | Method for synthesizing 1-substituted-1,2,3-tolyltriazole | UNIV TONGJI | 2012-07-25 | — | — | CN | disclosed |
| CN-102286047-A | 2'-deoxidized-2'-fluorin-4'-triazole substituted-beta-D cytidine analogue as well as preparation method and application thereof | — | 2011-12-21 | — | — | CN | disclosed |
| CN-102166211-A | Use of derivatives of 1-deoxynojiri mycin containing 1,2,3-triazoles as alpha-glucosidase inhibitors | UNIV FUDAN | 2011-08-31 | — | — | CN | disclosed |
| CN-102050795-A | Method for synthesizing 1-substituted-1, 2, 3-triazole from sodium acetylide | UNIV TONGJI | 2011-05-11 | — | — | CN | disclosed |
| CN-101792438-A | Method for synthesizing 1-substituted-1,2,3-tolyltriazole | UNIV TONGJI | 2010-08-04 | — | — | CN | disclosed |
| CN-101696206-A | Method for synthesizing 1-deoxynojirimycin derivatives containing 1,2,3-triazole | UNIV TONGJI | 2010-04-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127345-A1 | SELENOGALACTOSIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH GALECTIN AND THE USE THEREOF | LGALS1, LGALS3BP, LGALS2 | ALOX15 3056/4885MAP2K4 3585/4885ALDH1A1 3900/4885 |
| US-12291547-B2 | Synthesis of 3-azido-3-deoxy-D-galactopyranose | LGALS1, LGALS3, ST6GAL1 | ALOX15 1739/4885MAP2K4 4370/4885ALDH1A1 2390/4885 |
| US-20220251129-A1 | SYNTHESIS OF 3-AZIDO-3-DEOXY-D-GALACTOPYRANOSE | LGALS1, LGALS3, ST6GAL1 | ALOX15 1739/4885MAP2K4 4370/4885ALDH1A1 2390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.